PARLIAMENTARY WRITTEN QUESTION
Meningitis: Vaccination (2 February 2015)
Question Asked
To ask the Secretary of State for Health, what steps he is taking to ensure progress on price negotiations with Novartis for the Meningitis B vaccine.
Asked by:
Stuart Andrew (Conservative)
Asked by:
Stuart Andrew (Conservative)
Answer
We are seeking to reach a positive conclusion to the negotiations with Novartis for supply of the meningococcal B (MenB) vaccine, Bexsero® at a cost-effective price, as recommended by the Joint Committee on Vaccination and Immunisation as soon as possible. The introduction of an NHS MenB immunisation programme for infants will depend on the outcome of these negotiations.
Answered by:
Jane Ellison (Conservative)
5 February 2015
Contains Parliamentary information licensed under the Open Parliament Licence v3.0.